[Individualization of the surgical procedure in response to overdiagnosis and overtreatment in differentiated thyroid carcinomas].

J I Staubitz, T J Musholt
Author Information
  1. J I Staubitz: Sektion Endokrine Chirurgie, Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universitätsmedizin Mainz, Johannes Gutenberg-Universität Mainz, Langenbeckstraße 1, 55131, Mainz, Deutschland.
  2. T J Musholt: Sektion Endokrine Chirurgie, Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universitätsmedizin Mainz, Johannes Gutenberg-Universität Mainz, Langenbeckstraße 1, 55131, Mainz, Deutschland. musholt@uni-mainz.de.

Abstract

BACKGROUND: Advances in diagnostic methods have led to an early detection of thyroid nodules with debatable malignant potential in numerous cases. This can result in a potential overtreatment of thyroid lesions with very good prognosis.
OBJECTIVES: To avoid surgical overtreatment, an individualized, risk-adapted management is required that respects the different tumor biology of the underlying histological entities.
METHODS: The current guidelines of the leading professional societies, the American Thyroid Association (ATA) and the German Association of Endocrine Surgeons (CAEK), were compared and critically studied, to describe risk-adapted, more conservative treatment options for certain types of thyroid neoplasms according to the 2017 WHO definition.
RESULTS: The German CAEK recommends thyroidectomy as a routine operation in the case of thyroid carcinoma. Exceptions are papillary thyroid microcarcinoma and minimally invasive follicular thyroid carcinoma, which can be treated by lobectomy. The ATA proposes an "active surveillance" for papillary thyroid microcarcinoma and lobectomy in cases of differentiated thyroid carcinoma <4 cm in diameter in the absence of clearly predefined risk factors.
CONCLUSIONS: The pre- or intraoperative pathological diagnosis of the underlying tumor entity is the key point, which allows for an adaption of the resection strategy for thyroid malignancy. Depending on the type of carcinoma, the current guidelines of international expert societies allow for parenchyma-sparing operations and, according to the ATA, even an "active surveillance."

Keywords

References

  1. PLoS Genet. 2016 Aug 05;12(8):e1006239 [PMID: 27494611]
  2. World J Surg. 2012 May;36(5):1168-73 [PMID: 22366982]
  3. Nat Rev Dis Primers. 2015 Dec 10;1:15077 [PMID: 27188261]
  4. Nat Commun. 2018 Feb 8;9(1):579 [PMID: 29422527]
  5. Anticancer Res. 2009 Dec;29(12):5255-7 [PMID: 20044646]
  6. Ann Surg. 2009 Jun;249(6):1023-31 [PMID: 19474675]
  7. N Engl J Med. 2016 Aug 18;375(7):614-7 [PMID: 27532827]
  8. Thyroid. 2018 Feb;28(2):158-167 [PMID: 29281951]
  9. Virchows Arch. 2006 Apr;448(4):385-93 [PMID: 16506015]
  10. Nuklearmedizin. 2016 Jun 28;55(3):77-89 [PMID: 27350004]
  11. Eur Thyroid J. 2017 Jul;6(3):115-129 [PMID: 28785538]
  12. Nat Rev Cancer. 2013 Mar;13(3):184-99 [PMID: 23429735]
  13. JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22 [PMID: 24557566]
  14. Endocr Relat Cancer. 2016 Dec;23(12):893-897 [PMID: 27660403]
  15. JAMA Oncol. 2016 Aug 1;2(8):1023-9 [PMID: 27078145]
  16. Endocr Pathol. 2005 Winter;16(4):285-93 [PMID: 16627916]
  17. Dtsch Arztebl Int. 2016 May 20;113(20):353-9 [PMID: 27294815]
  18. Endocr Relat Cancer. 2014 Oct;21(5):T301-13 [PMID: 24829266]
  19. Am J Surg Pathol. 2013 Feb;37(2):282-6 [PMID: 23282969]
  20. Ann Surg. 2014 Oct;260(4):601-5; discussion 605-7 [PMID: 25203876]
  21. Langenbecks Arch Surg. 2013 Mar;398(3):347-75 [PMID: 23456424]
  22. Thyroid. 2019 Jan;29(1):7-26 [PMID: 30484394]
  23. Eur J Surg Oncol. 2011 Feb;37(2):181-5 [PMID: 21144693]
  24. Endocr Relat Cancer. 2018 Apr;25(4):R247-R258 [PMID: 29439059]
  25. Endocr Pathol. 2005 Winter;16(4):279-83 [PMID: 16627915]
  26. Surg Oncol. 2011 Mar;20(1):1-6 [PMID: 19596568]
  27. Thyroid. 2016 Jan;26(1):1-133 [PMID: 26462967]
  28. Endocr J. 2013;60(5):637-42 [PMID: 23327839]
  29. Thyroid. 2014 Jan;24(1):27-34 [PMID: 24001104]
  30. Thyroid. 2011 Jul;21(7):751-7 [PMID: 21615311]

MeSH Term

Carcinoma
Diagnosis, Differential
Humans
Medical Overuse
Thyroid Neoplasms
Thyroid Nodule
Thyroidectomy

Word Cloud

Created with Highcharts 10.0.0thyroidcarcinomaovertreatmentATApotentialcasescansurgicalrisk-adaptedtumorunderlyingcurrentguidelinessocietiesAssociationGermanCAEKaccordingpapillarymicrocarcinomalobectomy"activedifferentiatedsurveillanceBACKGROUND:AdvancesdiagnosticmethodsledearlydetectionnodulesdebatablemalignantnumerousresultlesionsgoodprognosisOBJECTIVES:avoidindividualizedmanagementrequiredrespectsdifferentbiologyhistologicalentitiesMETHODS:leadingprofessionalAmericanThyroidEndocrineSurgeonscomparedcriticallystudieddescribeconservativetreatmentoptionscertaintypesneoplasms2017WHOdefinitionRESULTS:recommendsthyroidectomyroutineoperationcaseExceptionsminimallyinvasivefolliculartreatedproposessurveillance"<4 cmdiameterabsenceclearlypredefinedriskfactorsCONCLUSIONS:pre-intraoperativepathologicaldiagnosisentitykeypointallowsadaptionresectionstrategymalignancyDependingtypeinternationalexpertallowparenchyma-sparingoperationseven"[Individualizationprocedureresponseoverdiagnosiscarcinomas]ActiveFollicularPapillaryThyroidectomy

Similar Articles

Cited By